- Home
- SELF vs ATNM Comparison
SELF vs ATNM Comparison
Compare SELF & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- ATNM
- Stock Information
- Founded
- SELF 1983
- ATNM 2000
- Country
- SELF United States
- ATNM United States
- Employees
- SELF N/A
- ATNM N/A
- Industry
- SELF Real Estate Investment Trusts
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- SELF Real Estate
- ATNM Health Care
- Exchange
- SELF Nasdaq
- ATNM Nasdaq
- Market Cap
- SELF 56.9M
- ATNM 46.5M
- IPO Year
- SELF N/A
- ATNM N/A
- Fundamental
- Price
- SELF $5.16
- ATNM $1.29
- Analyst Decision
- SELF
- ATNM Strong Buy
- Analyst Count
- SELF 0
- ATNM 4
- Target Price
- SELF N/A
- ATNM $8.75
- AVG Volume (30 Days)
- SELF 38.0K
- ATNM 470.9K
- Earning Date
- SELF 05-09-2025
- ATNM 05-06-2025
- Dividend Yield
- SELF 5.63%
- ATNM N/A
- EPS Growth
- SELF N/A
- ATNM N/A
- EPS
- SELF 0.19
- ATNM N/A
- Revenue
- SELF $12,530,280.00
- ATNM N/A
- Revenue This Year
- SELF N/A
- ATNM N/A
- Revenue Next Year
- SELF N/A
- ATNM N/A
- P/E Ratio
- SELF $27.11
- ATNM N/A
- Revenue Growth
- SELF 2.79
- ATNM N/A
- 52 Week Low
- SELF $4.16
- ATNM $1.03
- 52 Week High
- SELF $5.85
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- SELF 52.12
- ATNM 48.76
- Support Level
- SELF $4.79
- ATNM $1.17
- Resistance Level
- SELF $5.32
- ATNM $1.34
- Average True Range (ATR)
- SELF 0.18
- ATNM 0.13
- MACD
- SELF 0.02
- ATNM -0.01
- Stochastic Oscillator
- SELF 58.18
- ATNM 44.00
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.